Literature DB >> 3607755

Sex hormone response of a newly established squamous cell line derived from clinical esophageal carcinoma.

H Matsuoka, K Sugimachi, H Ueo, H Kuwano, S Nakano, M Nakayama.   

Abstract

Biopsy tissues from a 68-year-old Japanese man with metastases to axillary lymph nodes of a recurrent esophageal carcinoma were adapted to cell culture conditions and a continuously growing tumor cell line was developed. Immunohistochemical staining revealed that these cells contained keratinous material and the electron microscopic study revealed the presence of tonofilaments. Thus, this line, designated the KSE-1 line, was considered to have originated from metastatic squamous cell carcinoma of the esophagus. This line has a binding content of 4.2 fmol/mg protein for the estrogen receptor and 2.2 fmol/mg protein for the testosterone receptor. By measurement of cell number and thymidine incorporation, the growth rate of this line was found to be moderately responsive to these hormones, being inhibited by estrogen and enhanced by testosterone at concentration levels between 10(-13) and 10(-8) and 10(-13) and 10(-6) mg/ml, respectively.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3607755

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  21 in total

1.  Establishment of novel human esophageal cancer cell line in relation to telomere dynamics and telomerase activity.

Authors:  Y Kiyozuka; A Asai; D Yamamoto; H Senzaki; S Yoshioka; H Takahashi; K Hioki; A Tsubura
Journal:  Dig Dis Sci       Date:  2000-05       Impact factor: 3.199

2.  Androgen receptor promotes esophageal cancer cell migration and proliferation via matrix metalloproteinase 2.

Authors:  Yi Zhang; Tiecheng Pan; Xiaoxuan Zhong; Cai Cheng
Journal:  Tumour Biol       Date:  2015-02-28

Review 3.  Squamous cell carcinoma of the oesophagus: 10 years on.

Authors:  G A Khoury
Journal:  Ann R Coll Surg Engl       Date:  1991-01       Impact factor: 1.891

Review 4.  Androgens and esophageal cancer: What do we know?

Authors:  Olga A Sukocheva; Bin Li; Steven L Due; Damian J Hussey; David I Watson
Journal:  World J Gastroenterol       Date:  2015-05-28       Impact factor: 5.742

5.  Age and sex differences in the incidence of esophageal adenocarcinoma: results from the Surveillance, Epidemiology, and End Results (SEER) Registry (1973-2008).

Authors:  L N Mathieu; N F Kanarek; H-L Tsai; C M Rudin; M V Brock
Journal:  Dis Esophagus       Date:  2013-10-07       Impact factor: 3.429

6.  A novel isoform of human fibroblast growth factor 8 is induced by androgens and associated with progression of esophageal carcinoma.

Authors:  S Tanaka; H Ueo; K Mafune; M Mori; J R Wands; K Sugimachi
Journal:  Dig Dis Sci       Date:  2001-05       Impact factor: 3.199

7.  Expression of growth factors and their receptors in human esophageal carcinomas: regulation of expression by epidermal growth factor and transforming growth factor alpha.

Authors:  K Yoshida; H Kuniyasu; W Yasui; Y Kitadai; T Toge; E Tahara
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

8.  Influence of sex on the survival of patients with esophageal cancer.

Authors:  Pierre Bohanes; Dongyun Yang; Ruchika S Chhibar; Melissa J Labonte; Thomas Winder; Yan Ning; Armin Gerger; Léonor Benhaim; David Paez; Takeru Wakatsuki; Fotios Loupakis; Rita El-Khoueiry; Wu Zhang; Heinz-Josef Lenz
Journal:  J Clin Oncol       Date:  2012-05-14       Impact factor: 44.544

Review 9.  Regulation of sex hormone receptors in sexual dimorphism of human cancers.

Authors:  Daoshan Zheng; Cecilia Williams; Jeremy A Vold; Justin H Nguyen; Denise M Harnois; Sanjay P Bagaria; Sarah A McLaughlin; Zhaoyu Li
Journal:  Cancer Lett       Date:  2018-09-14       Impact factor: 8.679

10.  The oncogenomic function of androgen receptor in esophageal squamous cell carcinoma is directed by GATA3.

Authors:  Furong Huang; Hongyan Chen; Xiaolin Zhu; Tongyang Gong; Xukun Li; William Hankey; Hongyan Wang; Zhong Chen; Qianben Wang; Zhihua Liu
Journal:  Cell Res       Date:  2020-11-02       Impact factor: 25.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.